4//SEC Filing
LA JOLLA PHARMACEUTICAL CO 4
Accession 0001209191-07-000320
CIK 0000920465operating
Filed
Jan 2, 7:00 PM ET
Accepted
Jan 3, 12:02 PM ET
Size
8.0 KB
Accession
0001209191-07-000320
Insider Transaction Report
Form 4
JENN PAUL
VP of Product Development
Transactions
- Sale
Common Stock
2006-12-29$3.11/sh−5,000$15,541→ 6,804 total
Footnotes (1)
- [F1]The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan dated as of July 27, 2006.
Issuer
LA JOLLA PHARMACEUTICAL CO
CIK 0000920465
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000920465
Filing Metadata
- Form type
- 4
- Filed
- Jan 2, 7:00 PM ET
- Accepted
- Jan 3, 12:02 PM ET
- Size
- 8.0 KB